Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
COMPASS Pathways Plc - American Depository Shares
(NQ:
CMPS
)
6.390
+0.120 (+1.91%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Oct 18, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about COMPASS Pathways Plc - American Depository Shares
< Previous
1
2
...
19
20
21
22
23
24
25
26
Next >
Can Psychedelics Actually Cure Depression and PTSD?
May 25, 2021
There is now data suggesting that magic mushrooms and ecstasy -- combined with talk therapy -- may help people with severe depression and post-traumatic stress disorder.
Via
The Motley Fool
Topics
Cannabis
Exposures
Cannabis
Psychedelic Drug Developer Sets Sights On This Age-Old Hallucinogen
May 20, 2021
MindMed stock fell after it said a Swiss ethics committee cleared it to begin a study on the effects of the hallucinogen mescaline.
Via
Investor's Business Daily
Compass Pathways Offers Chance on Exploratory Mental Health Treatments
May 18, 2021
Over the past year, CMPS stock has been going nowhere fast. However, there's been recent progress in advancing psilocybin-assisted therapy.
Via
InvestorPlace
Psyched: MindMed And Compass Q1 Earnings, FDA Approves Therapists Taking MDMA, Wesana Health Goes Public
May 17, 2021
Two of the most prominent companies in the psychedelics space released their financials for the first quarter of 2021. Compass Pa...
Via
Benzinga
Exposures
Product Safety
Compass Releases Q1 Earnings: Strong Cash Position For Psilocybin R&D Efforts
May 14, 2021
Compass Pathways (NASDAQ:CMPS), a company researching psyc...
Via
Benzinga
How This Psychedelic Company Could Lead A Turnaround For The Sector
April 10, 2021
Compass Pathways PLC (NASDAQ:CMPS) is often viewed as the leader in the psychedeli...
Via
Benzinga
COMPASS Pathways plc (CMPS) Q1 2021 Earnings Call Transcript
May 13, 2021
CMPS earnings call for the period ending March 31, 2021.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
Cannabis Countdown: Top 10 Marijuana And Psychedelics Industry News Stories Of The Week
May 11, 2021
Welcome to the Cannabis Countdo...
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Benzinga's Top Ratings Upgrades, Downgrades For May 11, 2021
May 11, 2021
Upgrades For CEVA Inc (NASDAQ:CEVA), Barclays upgraded the previous rating of Equal-Weight to Overweight. For the first quarter, CEVA had an EPS of $0.01, compared to year...
Via
Benzinga
Why Smaller Psychedelics Companies Should Start Catching Up To The Sector Leaders
May 05, 2021
Concentration of ownership in psychedelic drug stocks has reached a new extreme. We explain how and why we don't see this trend as being sustainable.
Via
Talk Markets
The Next Psychedelic Stock To Uplist On The Nasdaq?
May 04, 2021
As MindMed Inc makes its long-awaited move to the Nasdaq, the obvious question is: who's next?
Via
Talk Markets
Cannabis Countdown: Top 10 Marijuana And Psychedelic Stock News Stories Of The Week
May 04, 2021
Cannabis Countdown: Top 10 Marijuana and Psychedelic Stock News Stories of the Week
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
April 28, 2021
Gainers Akari Therapeutics (NASDAQ:AKTX) stock moved upwards by 14.1% to $2.67 during Wednesday's pre-market session. The company's market cap stands at $102.7...
Via
Benzinga
Second-Chance Buying Opportunity With Psychedelic Stock Warrants
April 27, 2021
Psychedelic stock warrants delivered epic returns for investors in the big rally in these stocks in 2020. After the pullback in 2021, some of these warrants are again looking attractive.
Via
Talk Markets
MindMed Stock Climbs In Nasdaq Debut As Psychedelics Follow Pot's Path To Mainstream
April 27, 2021
MindMed stock rose in its Nasdaq listing debut on Tuesday, making it the latest psychedelic drug developer to land on a major U.S. exchange.
Via
Investor's Business Daily
Cannabis Countdown: Top 10 Marijuana And Psychedelic Stock News Stories Of The Week
April 27, 2021
Cannabis Countdown: Top 10 Marijuana and Psychedelic Stock News Stories of the Week
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Majority Of Pure-Play Psychedelic Drug Stocks Went Up Last Week
April 26, 2021
41 psychedelic drug stocks trade on the various North American stock exchanges and in the past week 24 went up, 12 went down and 5 had no change in price.
Via
Talk Markets
Psyched: MindMed, Atai Head For Nasdaq, Psychedelics Search Platforms Grow, Champignon Brands Resumes Trading
April 26, 2021
Two of the most highly funded companies in the psychedelics space announced plans last week to list on the Nasdaq exchange. Months after ...
Via
Benzinga
Déjà Vu: 2021 Slump In Psychedelic Stocks Mirrors 2020
April 21, 2021
Charts for most psychedelic drug stocks look terrible in recent weeks. The same was true in the summer of 2020 -- immediately before these stocks exploded higher. Deja vu?
Via
Talk Markets
Psychedelic Stocks: Atai Life Sciences IPO Seeks To Raise $100 Million
April 21, 2021
Atai Life Sciences hopes to raise $100 million in an initial public offering, as other psychedelic stocks seek investor cash.
Via
Investor's Business Daily
Topics
Initial Public Offering
Exposures
Securities Market
Cannabis Countdown: Top 10 Marijuana And Psychedelic Stock News Stories Of The Week, 4/20/2021
April 20, 2021
Welcome to the Cannabis...
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Psyched: California Psychedelics Bill Passes Second Committee, GH Research Closes $125M Series B, Study Shows Psilocybin Could Equal SSRI Results In Depression
April 19, 2021
A bill that would remove penalties for the possession, personal use and social sharing of certain natural and synthetic psychedelics in Califo...
Via
Benzinga
Pure-Play Psychedelic Drug Stocks Index Declined 5.7% This Week
April 17, 2021
In the past week, of the 41 psychedelic drug stocks that trade on the various North American stock exchanges only nine went up, in price while 31 went down and one had no change.
Via
Talk Markets
The Daily Biotech Pulse: Merck Shelves 2 COVID-19 Studies, Bristol-Myers Squibb Gets European Regulatory Nod, InspireMD's Reverse Split
April 15, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 14) 10x Genomics, Inc. (NASDAQ...
Via
Benzinga
Exposures
COVID-19
Cannabis Countdown: Top 10 Marijuana And Psychedelic Stock News Stories Of The Week
April 13, 2021
Welcome to the Cannabis...
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Psychedelic Stocks Primed For Atai-MindMed Bounce
April 08, 2021
It's now looking like the atai Life Sciences IPO and the MindMed uplisting to the Nasdaq could occur within weeks of each other. We point out what that means for investors in psychedelic stocks.
Via
Talk Markets
Topics
Initial Public Offering
Exposures
Securities Market
< Previous
1
2
...
19
20
21
22
23
24
25
26
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.